| Name | MBNL1 antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have identified MBNL1‐AS1 as a crucial long non‐coding RNA involved in the modulation of tumorigenesis in various cancers. In non‐small cell lung cancer, its potential role is under investigation, whereas in bladder cancer, downregulation of MBNL1‐AS1 is linked to enhanced cell proliferation, accelerated cell cycle progression, and reduced apoptosis – effects mediated through the miR‑135a/PHLPP2/FOXO1 axis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn other malignancies, MBNL1‐AS1 consistently functions as a tumor suppressor by modulating key signaling pathways via microRNA sponging. In prostate cancer, overexpression of MBNL1‐AS1 inhibits cell proliferation, invasion, and migration by sequestering miR‑181a‑5p, thereby upregulating PTEN and dampening the PI3K/AKT/mTOR cascade. Similarly, in gastric cancer its downregulation fuels tumor growth and metastasis through the miR‑424‑5p/Smad7 axis with consequent activation of TGF‑β/EMT signaling. In breast cancer, two independent studies have demonstrated that lower levels of MBNL1‑AS1 promote proliferation, invasion, migration, and even glycolytic metabolism by targeting miR‑423‑5p (affecting CREBZF) and miR‑889‑3p (modulating KLF9), respectively. Moreover, in pancreatic adenocarcinoma, MBNL1‑AS1 overexpression curtails cell proliferation, migration, and epithelial–mesenchymal transition by downregulating miR‑301b‑3p, and in colorectal cancer, it suppresses tumor cell growth by sponging miR‑129c‑13p to stabilize BVES mRNA."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOutside of oncogenesis, MBNL1‐AS1 is also linked to non‐cancerous pathologies. The broader muscleblind‐like protein family, including MBNL1, is critical for RNA splicing during muscle and neuronal differentiation, with its inactivation being a hallmark of myotonic dystrophy and related neuromuscular and cardiac dysfunctions. Additionally, emerging evidence suggests a role for MBNL1‐AS1 in cardiovascular pathology, including myocardial infarction, where it may help regulate cellular responses during tissue injury."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Peng Li, Wenqun Xing, Jinliang Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Stem Cell Res Ther (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13287-019-1235-8"}], "href": "https://doi.org/10.1186/s13287-019-1235-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31113460"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31113460"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiaosong Wei, Xiaoming Yang, Beibei Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2684"}], "href": "https://doi.org/10.1002/cam4.2684"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31769229"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31769229"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Xiang Ding, Xu Xu, Xue-Feng He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1890383"}], "href": "https://doi.org/10.1080/21655979.2021.1890383"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33648424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33648424"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jiewen Su, Dawei Chen, Yi Ruan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MBNL1-AS1 represses gastric cancer progression via the TGF-β pathway by modulating miR-424-5p/Smad7 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2037921"}], "href": "https://doi.org/10.1080/21655979.2022.2037921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35311623"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35311623"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Jun Fang, Gaohui Jiang, Weiguo Mao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulation of long noncoding RNA MBNL1-AS1 suppresses breast cancer progression by modulating miR-423-5p/CREBZF axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2026728"}], "href": "https://doi.org/10.1080/21655979.2022.2026728"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35094653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35094653"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yongmei Jin, Lingli Xu, Bin Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumour-suppressing functions of the lncRNA MBNL1-AS1/miR-889-3p/KLF9 axis in human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2022.2034254"}], "href": "https://doi.org/10.1080/15384101.2022.2034254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35112997"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35112997"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chouman Sulidankazha, Alidake, Hai Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genet Res (Camb) (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2023/6785005"}], "href": "https://doi.org/10.1155/2023/6785005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36908851"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36908851"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wang-Sheng Chen, Xu Zhang, Zheng-Fei Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MBNL1‑AS1 attenuates tumor cell proliferation by regulating the miR‑29c‑3p/BVES signal in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2023.8628"}], "href": "https://doi.org/10.3892/or.2023.8628"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37711058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37711058"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Qi Zhang, Yinxin Wu, Jinlan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Regulatory Role of Both MBNL1 and MBNL1-AS1 in Several Common Cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Pharm Des (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1381612827666210830110732"}], "href": "https://doi.org/10.2174/1381612827666210830110732"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34459372"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34459372"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yanbing Li, Min Zong, Xiaonan Guan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MBNL1-AS1 Promotes Hypoxia-Induced Myocardial Infarction via the miR-132-3p/RAB14/CAMTA1 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oxid Med Cell Longev (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2023/3308725"}], "href": "https://doi.org/10.1155/2023/3308725"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36785792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36785792"}]}]}]}
|
| NCBI Gene ID | 401093 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MBNL1-AS1 has 274 functional associations with biological entities spanning 4 categories (chemical, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.
Click the + buttons to view associations for MBNL1-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MBNL1-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MBNL1-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MBNL1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MBNL1-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MBNL1-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MBNL1-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MBNL1-AS1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MBNL1-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MBNL1-AS1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |